Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma

Matteo Angelo Manini; Angelo Sangiovanni; Fabio Fornari; Fabio Piscaglia; Marco Biolato; Libera Fanigliulo; Elisa Ravaldi; Antonio Grieco; Massimo Colombo

doi:10.1016/j.jhep.2014.01.006

Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma

Matteo Angelo Manini, Angelo Sangiovanni, Fabio Fornari, Fabio Piscaglia, Marco Biolato, Libera Fanigliulo, Elisa Ravaldi, Antonio Grieco, Massimo Colombo

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo in rivista

41 Citazioni (Scopus)

Abstract

Although contrast-enhanced computed tomography (CT), dynamic magnetic resonance (MRI) and fine needle biopsy (FNB) are the standard of care to diagnose hepatocellular carcinoma (HCC), the clinical and economic benefits of the updated AASLD diagnostic algorithm, including the drop of contrast enhanced ultrasound (CEUS), have not been previously evaluated.

Lingua originale	English
pagine (da-a)	995-1001
Numero di pagine	7
Rivista	Journal of Hepatology
Volume	60
DOI	https://doi.org/10.1016/j.jhep.2014.01.006
Stato di pubblicazione	Pubblicato - 2014

Keywords

Cirrhosis
Clinical guidelines
Hepatocellular carcinoma
Imaging techniques
Surveillance

Accesso al documento

10.1016/j.jhep.2014.01.006

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{2f5d9f3acd04461c86d951d244f2e198,

title = "Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma",

abstract = "Although contrast-enhanced computed tomography (CT), dynamic magnetic resonance (MRI) and fine needle biopsy (FNB) are the standard of care to diagnose hepatocellular carcinoma (HCC), the clinical and economic benefits of the updated AASLD diagnostic algorithm, including the drop of contrast enhanced ultrasound (CEUS), have not been previously evaluated.",

keywords = "Cirrhosis, Clinical guidelines, Hepatocellular carcinoma, Imaging techniques, Surveillance, Cirrhosis, Clinical guidelines, Hepatocellular carcinoma, Imaging techniques, Surveillance",

author = "Manini, {Matteo Angelo} and Angelo Sangiovanni and Fabio Fornari and Fabio Piscaglia and Marco Biolato and Libera Fanigliulo and Elisa Ravaldi and Antonio Grieco and Massimo Colombo",

year = "2014",

doi = "10.1016/j.jhep.2014.01.006",

language = "English",

volume = "60",

pages = "995--1001",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma

AU - Manini, Matteo Angelo

AU - Sangiovanni, Angelo

AU - Fornari, Fabio

AU - Piscaglia, Fabio

AU - Biolato, Marco

AU - Fanigliulo, Libera

AU - Ravaldi, Elisa

AU - Grieco, Antonio

AU - Colombo, Massimo

PY - 2014

Y1 - 2014

N2 - Although contrast-enhanced computed tomography (CT), dynamic magnetic resonance (MRI) and fine needle biopsy (FNB) are the standard of care to diagnose hepatocellular carcinoma (HCC), the clinical and economic benefits of the updated AASLD diagnostic algorithm, including the drop of contrast enhanced ultrasound (CEUS), have not been previously evaluated.

AB - Although contrast-enhanced computed tomography (CT), dynamic magnetic resonance (MRI) and fine needle biopsy (FNB) are the standard of care to diagnose hepatocellular carcinoma (HCC), the clinical and economic benefits of the updated AASLD diagnostic algorithm, including the drop of contrast enhanced ultrasound (CEUS), have not been previously evaluated.

KW - Cirrhosis

KW - Clinical guidelines

KW - Hepatocellular carcinoma

KW - Imaging techniques

KW - Surveillance

KW - Cirrhosis

KW - Clinical guidelines

KW - Hepatocellular carcinoma

KW - Imaging techniques

KW - Surveillance

UR - http://hdl.handle.net/10807/61669

U2 - 10.1016/j.jhep.2014.01.006

DO - 10.1016/j.jhep.2014.01.006

M3 - Article

SN - 0168-8278

VL - 60

SP - 995

EP - 1001

JO - Journal of Hepatology

JF - Journal of Hepatology

ER -

Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo